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Abstract
Purpose: To study the impacts of multileaf collimators (MLC) width [standard MLC width of 10 mm (sMLC) and micro-
MLC width of 4 mm (mMLC)] in the intensity-modulated radiotherapy (IMRT) planning for the upper thoracic 
esophageal cancer (UTEC).
Methods and materials: 10 patients with UTEC were retrospectively planned with the sMLC and the mMLC. The 
monitor unites (MUs) and dose volume histogram-based parameters [conformity index (CI) and homogeneous index 
(HI)] were compared between the IMRT plans with sMLC and with mMLC.
Results: The IMRT plans with the mMLC were more efficient (average MUs: 703.1 ± 68.3) than plans with the sMLC 
(average MUs: 833.4 ± 73.8) (p < 0.05). Also, compared to plans with the sMLC, the plans with the mMLC showed 
advantages in dose coverage of the planning gross tumor volume (Pgtv) (CI 0.706 ± 0.056/HI 1.093 ± 0.021) and the 
planning target volume (PTV) (CI 0.707 ± 0.029/HI 1.315 ± 0.013) (p < 0.05). In addition, the significant dose sparing in 
the D5 (3260.3 ± 374.0 vs 3404.5 ± 374.4)/gEUD (1815.1 ± 281.7 vs 1849.2 ± 297.6) of the spinal cord, the V10 (33.2 ± 6.5 
vs 34.0 ± 6.7), V20 (16.0 ± 4.6 vs 16.6 ± 4.7), MLD (866.2 ± 174.1 vs 887.9 ± 172.1) and gEUD (938.6 ± 175.2 vs 956.8 ± 171.0) 
of the lungs were observed in the plans with the mMLC, respectively (p < 0.05).
Conclusions: Comparing to the sMLC, the mMLC not only demonstrated higher efficiencies and more optimal target 
coverage, but also considerably improved the dose sparing of OARs in the IMRT planning for UTEC.
Introduction
Upper thoracic esophageal carcinoma (UTEC) occurs
rarely and accounts for only 5%-10% of all esophageal car-
cinomas in PR.China [1]. Surgery operation has not been
an appropriate treatment for those with locally advanced
tumors because it was difficult to achieve a clear margin.
Therefore, for diseases located in the upper thoracic
region, including cervical region, radiotherapy is an effi-
cient treatment selection. To achieve a higher tumor local
control, the radiation doses of 60-70 Gy to primary
tumors and approximately 50-55 Gy to electively irradi-
ated lymph nodal regions are necessary.
Due to the significant anatomical variations inside the
human bodies, it has always been a challenge to deal with
the target conformity and organs at risk (OARs) sparing
in radiotherapy for some special kinds of tumors, includ-
ing UTEC. In the last two decades, IMRT has gained wide
acceptance as a state-of-art technique to treat those spe-
cial tumors. It can successfully add the modulation of
beam intensity to beam shaping along the radiation pene-
tration direction and improves the dose conformity of the
targets and also reduce the unnecessary radiation to the
OARs [2-4].
During IMRT dose delivery, if the anatomy location
between targets and OARs is very close and complicated,
the MLC leaf width may have an effect on the dose distri-
bution of the targets and the protection for OARs.
Recently, several studies investigated the impacts of the
MLC leaf width on the treatment planning for several
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kinds of tumors, and the results are controversial [5-11].
Further evaluations for the potential advantage of small
leaf width on IMRT planning for UTEC are necessary.
Here, for the first time, we conducted an original study
of comparing impacts of MLC leaf width in IMRT plan-
ning for UTEC. All IMRT plans were generated according
to two Elekta commercial MLC devices and all of opera-
tions and software applied were performed in our therapy




The sMLC is the MLC device equipped in the Elekta Pre-
cise Treatment System (Elekta Oncology System, Swe-
den). The leaf width of this MLC is 10 mm at isocenter. It
has 40 leaf pairs, upper jaws and backup jaws, covering a
full 40 × 40-cm field. The total leaf travel distance is 32.5
cm. There is a minimum leaf gap across banks.
The mMLC is another commercial Elekta system
installed newly in our center, the Elekta Beam Modula-
tor™(Elekta Oncology Systems, Crawley, UK) [12]. It con-
sists of 40 opposed pairs of leaves. Each individual leaf is
capable of interdigitation and projects a width of 4 mm at
the isocenter. The maximum allowable field size is 16 cm
across the leaf bank and 22 cm in the direction of leaf
travel.
Patient Data
This study was conducted between March 2008 and
October 2009. In total 10 patients with pathologically
confirmed UTEC were retrospectively evaluated in pres-
ent study. The median age of the 10 patients was 48 years
old (range, 39-61 years). One woman and nine men were
included. All patients were staged according to the 1997
UICC/AJCC staging system [13]. The basic and clinical
characteristics of the 10 patients were summarized in
Table 1. Permission to conduct the study was granted by
the Research Ethics Board of the University Health Net-
work. 6 patients received treatment with the sMLC sys-
tem and 4 patients received treatment with the mMLC
system.
Targets Delineation and Dose Prescription
All of patients in this study underwent a dedicated helical
computed tomography (CT, Siemens, Somatom Plus4)
with 3 mm slice thickness in the supine position through-
out the entire neck and thorax. The entire lungs were
scanned for further plan evaluation. All patients were CT
scanned during normal breathing. Six of the 10 patients
were immobilized with head and neck/upper thoracic
thermoplastic masks, and the rest with vacuum-locked
cradles. All of the CT images of patients acquired were
transferred to and registered in the TPS with a standard
of couch removal and laser center localization.
All of the targets and normal tissues definitions in this
study were in accordance with the RTOG 50 and 62
reports [14,15]. The gross tumor volume (GTV) included
all known gross diseases (primary tumor plus grossly
enlarged lymph nodes) as determined by the imaging,
clinical, and endoscopic findings. The clinical target vol-
ume (CTV) included correlated lymphatic drainage
regions and extended to cricothyroid membranes. It was
approximately defined as the GTV plus a 3- to 4-cm mar-
gin superior to the highest extension of the tumor and a
4-cm margin inferior to the lowest extension of the tumor
with a 2-cm radial margin. Uninvolved bony structures
and lung tissues were kept outside the CTV. The Pgtv and
PTV were defined as the GTV and CTV plus a 0.3 cm
margin in all direction, respectively. The spinal cord and
lungs were contoured as OARs.
The planned treatment for each patient consisted of
64.5 Gy to be delivered to Pgtv in 30 fractions, 54 Gy to
Table 1: Basic and clinical characteristics of the study 












Length of Pgtv (cm)
Median 9.4
Range 8.3-11.5
Volume of Pgtv (cm3)
Median 94.1
Range 62.9-121.8
Length of PTV (cm)
Median 16.2
Range 15.2-17.5
Volume of PTV (cm3)
Median 278.5
Range 228.4-327.9
Volume of total lung (cm3)
Median 3532.6
Range 2774.2-4888.1
Pgtv: planning gross target volume; PTV: planning target volume.Gong et al. Radiation Oncology 2010, 5:65
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PTV in 30 fractions; and the prescription dose covered at
least 95% of the volume of Pgtv and PTV , respectively .
The maximum tolerance doses to the critical normal
structures were as follows: spinal cord 45 Gy) and
lungsV20 less than 30% and V30 less than 15%.
Treatment Planning and Optimizing
In the progress of treatment planning setup and optimiz-
ing, all of the inverse IMRT plans were generated and
evaluated using TPS mentioned previously. The plans
were performed on the basis of 7 coplanar beams
arrangement, whose angels were 204°, 256°, 308°, 0°, 52°,
104° and 156°, respectively. As mentioned previously, the
TPS of Philips Pinnacle3  version 8.0 m used Direct
Machine Parameter Optimization method (DMPO, Ray-
search™ laboratories, Stockholm, Sweden) in IMRT plans
optimizing proceeding. The IMRT plan optimizing based
on two MLC devices generated with the identical dose
constrains and optimization parameters. For all ten
patients, the parameters were same too. The max itera-
tions of the plan optimizing were 40, and the maximum
numbers of all segments in one plan were restricted
within 100. There is no limitation in the minimum MUs
per segment.
Evaluation of the DVH-based Parameters
In this study, the CI was calculated for Pgtv and PTV
among plans respectively, as the equation used by Zhu et
al. [5]: CI = Pgtvref/Pgtv × Pgtvref/Vref. The Pgtvref is the
overlap volume between the Pgtv and volume of prescrip-
tion isodose surface. The Vref is tissue volume that is
enclosed by the prescription isodose surface also outside
of Pgtv. The prescription isodose was 95% isodose to
Pgtv. The same method was applied in analysis of PTV.
The higher CI is, the more conformal the plan is.
The HI for targets was defined as "HI = D5/D95", where
D5 and D95 are the dose received by the 5% and 95% vol-
umes of Pgtv and PTV . The more D5 and D95 approach
each other, the steeper the target's curve in DVHs. The
optimal value of the HI is 1.
The generalized equivalent uniform dose (gEUD) of the
OARs was calculated by the TPS automatically.
Statistical Analysis
The statistical analysis was performed using the SPSS
software (version 13.0, Chicago, USA). All data were ana-
lyzed applying "mean ± SD". Using Student's t-test, a
value of p < 0.05 (two-tailed) was considered statistically
significance.
Results
In total, 20 plans based on the different MLC devices
were generated after the protocol and analyzed. The rep-
resentative IMRT plans of one patient with irradiation
isodose curves were shown in Fig. 1 and which revealed
i s o d o s e  c u r v e s  w e r e  s i m i l a r  w i t h  e a c h  o t h e r .  F i g .  2
showed the case-by-case comparison of the delivering
MUs between these paired IMRT plans, indicating that
the average MUs with the mMLC (703.1 ± 68.3) was more
lower than those with the sMLC (833.4 ± 73.8) (p  <
0.001).
Dose Coverage of the Targets
The evaluation of the DVH-based parameters of the tar-
gets was shown in table 2. The maximum, minimum and
average dose of Pgtv and the average dose of PTV were
similar between these two IMRT plans, respectively, with
no statistical significance (p > 0.05).
The comparisons of the dose conformity for the targets
in present study were summarized in Table 3. The aver-
age CI for Pgtv (0.706 ± 0.056) and PTV (0.707 ± 0.029) in
IMRT plans with mMLC, were significantly better than
those in plans with sMLC (for Pgtv 0.677 ± 0.086 and for
PTV 0.699 ± 0.029), respectively (p  < 0.05). Also, the
average HI for Pgtv (1.093 ± 0.021) and PTV (1.315 ±
0.013) in IMRT plans with the mMLC were better than
those in plans with the sMLC (for Pgtv 1.105 ± 0.024 and
for PTV 1.335 ± 0.016) respectively, with statistically sig-
nificance (p < 0.01).
Dose Sparing of the OARs
Table 4 showed the comparisons of the DVH-based
parameters of the spinal cord in the present study. Com-
pared with the plans with the sMLC, the plans with
mMLC had significant advantages in dose sparing of the
spinal cord. The differences of the D5 and gEUD between
the two series were statistical significant, respectively (p <
0.05). However, there was no statistical significance
observed among the differences of the Dmax of the spinal
cord between the two series (p > 0.05).
Meanwhile, table 4 also showed the comparisons of the
dosimetric parameters of the lungs in detail, in the pres-
Figure 1 The transverse sections of the representative IMRT 
plans of one patient with the irradiation isodose curves (10 and 4 
mm: MLC leaf widths of 10 and 4 mm, respectively).Gong et al. Radiation Oncology 2010, 5:65
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ent study. Although the differences of the V5 and V30
between the two series were not statistically significant,
the IMRT plans with the mMLC had clearly advantages in
the differences of the V10 (33.2 ± 6.5 vs 34.0 ± 6.7, p <
0.01), V20 (16.0 ± 4.6 vs 16.6 ± 4.7, p < 0.01), MLD (866.2 ±
174.1 vs 887.9 ± 172.1, p < 0.01) and gEUD (938.6 ± 175.2
vs 956.8 ± 171.0, p < 0.02) respectively, compared with
those with the sMLC.
Discussions
For the first time, we initiated a study focusing on the
dosimetric differences between the two kinds of IMRT
plans for UTEC with the 10-mm leaf width MLC and 4-
mm leaf width MLC The results of this study indicated
that the small leaf widths could improve conformity of
the targets and OARs.
It is intuitive that a smaller leaf width MLC should
result in a better beam shaping. To achieve this goal, the
smaller leaf width MLC, commonly called "micro-" or
"mini"-MLC (mMLC) and with the leaf widths between
1.6 and 4.5 mm defined at the isocenter, were designed
and developed [16-20]. Several studies on the dosimetric
impacts of MLC leaf widths were conducted and have
confirmed dosimetric advantage in conformal radiother-
apy and IMRT planning for different tumors with smaller
leaves. Kubo et al. firstly compared the conformity of 3 D
conformal planning using a 1.7 mm leaf width, a 3 mm
leaf-width, and 10 mm leaf-width MLCs [21]. Monk et al.
evaluated the 3-mm and 5-mm MLC for intracranial
radiosurgery and found that the 3-mm leaf width MLC
improves targets' conformity, although the quantitative
differences may not be clinically significant for some
cases [6]. Dvorak et al. reported that the micro-MLC
showed significantly better conformity values compared
with the standard IMRT plans using a regular MLC, they
compared 10 mm and 3 mm leaf width MLC in stereotac-
tic body radiotherapy of liver and lung lesions [22]. Jin
and colleagues reported that the 3-mm MLC had a better
dose conformity in treatment plans than those of the 5
and 10-mm MLCs [8]. To be similar with these studies,
our data demonstrated that in IMRT treatment for
UTEC, the plans with mMLC had the optimal dose cov-
erage for targets (CI: Pgtv 0.706 ± 0.056 and PTV 0.707 ±
0.029) and better dose homogeneity (HI: Pgtv 1.093 ±
0.021 and PTV 1.315 ± 0.013), than the plans with the
sMLC (CI: Pgtv 0.677 ± 0.086 and PTV 0.699 ± 0.029; HI:
Pgtv 1.105 ± 0.024 and PTV 1.335 ± 0.016) with statisti-
cally significance (p < 0.05). As mentioned above, data
from the previous and present studies stated that the
smaller MLC leaf widths are, the better the dose optimi-
zation of an IMRT plan would be. However, on the basis
of these literatures, it is definite that the impact of the
MLC leaf width on IMRT planning and delivery depends
on the size and shape of the targets.
There have been several studies that have evaluated the
mMLC to improve the surrounding normal tissue spar-
ing, compared with the sMLC. Wang et al. observed that
there would be the significant reductions in the volume of
rectum receiving medium to higher doses in IMRT plans
with the mMLC for prostate cancer. In IMRT plans with
mMLC, the average decrease in the volume of the rectum
receiving 40, 50, and 60 Gy was 40.2%, 33.4%, and 17.7%,
Figure 2 Case-by-case comparison of the delivering MUs be-
tween the IMRT plans with the mMLC and the sMLC (10 and 4 mm: 
MLC leaf widths of 10 and 4 mm, respectively).
Table 2: Comparisons of the DVH-based parameters for targets in the present study (n = 10).
Targets MLC leaf width
10 mm 4 mm p value
Pgtv
Dmax 7056.1 ± 127.2 6996.3 ± 88.9 0.24
Dmin 6035.5 ± 113.7 6132.2 ± 107.4 0.06
Dmean 6495.2 ± 39.0 6491.1 ± 30.4 0.44
PTV
Dmean 5478.5 ± 78.4 5489.2 ± 64.3 0.74
DVH: dose volume histogram; MLC: multileaf collimator; Pgtv: planning gross target volume; PTV: planning target volume; Dmax, Dmin and 
Dmean: the maximum, minimum and average irradiation dose of the targets received.Gong et al. Radiation Oncology 2010, 5:65
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respectively. The mean dose reductions for D17 and D35
for the rectum were 20.0% and 18.3%, respectively, com-
pared with the plans with the sMLC [9]. Wu et al. found
that in radiosurgery for the small lesions, the complex
target-OARs space structures would especially benefit
from the use of a smaller leaf-width MLC [7]. The same
conclusions were reported by other researchers
[8,11,12,23]. In our study, we observed that the plans with
the mMLC had apparent advantage on dose sparing of
the spinal cord (D5 and gEUD), especially when target
was very close to the spinal cord, compared with the
plans with the sMLC,. For lungs, the mMLC was still
superior to the sMLC in the dose sparing in the V10, V20,
MLD and gEUD. Although these differences we observed
were somewhat small or even ignored in practice, our
results still revealed that the mMLC has more advantages
than the sMLC and represented the ongoing progress of
the precise radiotherapy techniques.
The limitation of this study should also be addressed. In
plan generation, the DMPO method was applied. During
the first optimization step for 2-step optimization, the
optimizer generates a continuous intensity-modulated
profile for each user-selected beam while minimizing the
value of the cost function with in a set number of total
iterations [23]. The IMRT optimization in Pinnacle with
DMPO starts with a conformal beam of uniform intensity
followed by four steps of fluence optimization. This is fol-
lowed by a step that includes machine parameters: leaf-
positions and segment weights are varied within the lim-
its of the linear accelerator. With DMPO, there are addi-
tional parameters that can be defined by the treatment
planner, including the max iterations of plan optimizing,
the maximum numbers of all segments and the minimum
monitor units (MUs) per segment. Different planner may
set up different parameters based on different clinical
conditions. Ludlum et al. showed that the iterations num-
ber is 15 are sufficient for convergence of the cost func-
tion for most clinical cases [24]. Asselen et al. considered
that the maximum number of segments is a soft con-
straint of the optimization process. In their experiences,
the number of initial iterations was 10 [25]. In addition,
Ludlum  et al. and Bratengeiera et al. respectively
expressed increasing iteration number does not improve
the plan quality significantly [24,26]. As our focus in this
study was to compare two kinds of MLCs, we directly set
up the max iterations of plan optimizing and the maxi-
mum numbers of all segments in DMPO optimization
based on our daily clinical practice and did not compare
the plans with different DMPO steps.
This work has been purely a theoretical planning study
and no attempt has been made to measure the dose dis-
tribution delivered in practice based on the two MLC
devices. The actual physical dose delivered to patients
could be affected by many other factors such as beam
penumbra modeling, setup uncertainty, organ motions.
The clinical significance on these results would deserve




CI HI CI HI
10 mm 4 mm 10 mm 4 mm 10 mm 4 mm 10 mm 4 mm
1 0.709 0.740 1.090 1.083 0.684 0.672 1.357 1.341
2 0.665 0.690 1.094 1.087 0.676 0.688 1.347 1.323
3 0.721 0.721 1.090 1.086 0.725 0.734 1.318 1.304
4 0.689 0.725 1.095 1.074 0.708 0.723 1.337 1.317
5 0.438 0.553 1.108 1.087 0.668 0.677 1.351 1.324
6 0.684 0.706 1.145 1.134 0.718 0.734 1.330 1.310
7 0.720 0.737 1.151 1.128 0.708 0.728 1.349 1.320
8 0.699 0.730 1.093 1.087 0.652 0.671 1.311 1.296
9 0.719 0.734 1.080 1.074 0.700 0.699 1.328 1.312
10 0.722 0.727 1.101 1.089 0.750 0.748 1.322 1.302
Average 
(mean ± SD)
0.677 ± 0.086 0.706 ± 0.056 1.105 ± 0.024 1.093 ± 0.021 0.699 ± 0.029 0.707 ± 0.029 1.335 ± 0.016 1.315 ± 0.013
p value 0.008 0.001 0.03 0.007
CI: conformity index; HI: homogeneous index; Pgtv: planning gross target volume; PTV: planning target volume; 10 and 4 mm: multileaf 
collimator leaf widths as 10 and 4 mm, respectively.Gong et al. Radiation Oncology 2010, 5:65
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further investigation. It is noteworthy that the MLC leaf
width is not the only parameter affecting the IMRT plans.
Other factors could also be included, such as the leaf
transmission, leakage radiation, the source MLC distance.
Conclusions
The mMLC not only resulted in a dosimetric improve-
ment in OARs' protection in the IMRT plans for UTEC
compared with the sMLC, but also ensured the improve-
ment of the dose delivery efficiency and the target dose
coverage. Because of its superior ability to spare normal
tissues, the use of sMLC may improve the therapeutic
ratio by reducing the toxicity to the adjacent OARs dur-
ing IMRT delivery.
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